版本:
中国

BRIEF-Gemphire Therapeutics announces publication of Phase 2 data for Gemcabene

Sept 19 Gemphire Therapeutics Inc :

* Gemcabene, when added to stable statin therapy, resulted in a clinically meaningful reduction in LDL-C

* Gemphire Therapeutics announces publication of Phase 2 data for Gemcabene in the journal of clinical lipidology Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐